@blessienelson.bsky.social
Reposted
Follow MD Anderson’s experts on Bluesky to keep up with the latest cancer research and information. #EndCancer
January 3, 2025 at 3:00 PM
Follow MD Anderson’s experts on Bluesky to keep up with the latest cancer research and information. #EndCancer
Reposted
🎥 @naborala.bsky.social of @mdanderson.bsky.social discusses Phase II trial findings on neoadjuvant enzalutamide & paclitaxel in LAR-enriched #TNBC. Promising response rates & IHC/RNA sequencing alignment:
➡️ https://buff.ly/4iRnvIj ⬅️
@sabcs.bsky.social #SABCS24 #BreastCancer
➡️ https://buff.ly/4iRnvIj ⬅️
@sabcs.bsky.social #SABCS24 #BreastCancer
Phase II trial results on enzalutamide and paclitaxel in LAR-enriched TNBC - VJOncology
Bora Lim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides a brief overview on the Phase...
buff.ly
December 30, 2024 at 3:54 PM
🎥 @naborala.bsky.social of @mdanderson.bsky.social discusses Phase II trial findings on neoadjuvant enzalutamide & paclitaxel in LAR-enriched #TNBC. Promising response rates & IHC/RNA sequencing alignment:
➡️ https://buff.ly/4iRnvIj ⬅️
@sabcs.bsky.social #SABCS24 #BreastCancer
➡️ https://buff.ly/4iRnvIj ⬅️
@sabcs.bsky.social #SABCS24 #BreastCancer